The SCIPP project team is led by OU and Louisiana State University with collaborators at the University of Kansas, University of
Nebraska-Lincoln and Texas A&M University.
Five were public schools: University of Illinois at Urbana-Champaign, Southern Illinois University Carbondale, University of Kansas, University of
Missouri and Eastern Kentucky University.
Companies Mentioned in this Report: Acorda Therapeutics, Inc., Adamis Pharmaceuticals Corporation, Advent Pharmaceuticals Pty Ltd, Aespira Ltd., AKELA Pharma Inc., Bayer HealthCare AG, Bespak Europe Ltd., GlaxoSmithKline Plc, Hovione FarmaCiencia SA, MannKind Corporation, Nanotherapeutics, Inc., Nektar Therapeutics, Novartis AG, OPKO Health, Inc., Pharmaxis Limited, Respira Therapeutics, Inc., Sandoz International GmbH, Sheffield Hallam University, Shin Nippon Biomedical Laboratories, Ltd., Teva Pharmaceutical Industries Ltd., University of Kansas, University of
Texas Medical Branch at Galveston
The exclusive MascotWear program will debut with 22 collegiate institutions including The University of Alabama, The University of Arizona, University of Arkansas, Auburn University, Clemson University, University of Florida, University of Georgia, University of Illinois, University of Kansas, University of
Kentucky, Louisiana State University, University of Mississippi, University of Missouri, University of Nebraska, University of North Carolina, Oklahoma State University, University of South Carolina, University of Tennessee, The University of Texas, Texas Tech University, West Virginia University, and University of Wisconsin.